Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck

Investor Deadline Approaching: Faruqi & Faruqi LLP Investigates Claims on Behalf of Investors of Novo

New York, NY – Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating claims against Novo (NASDAQ: NVTO) on behalf of investors who purchased the Company's securities between April 29, 2021 and March 8, 2023.

The investigation is centered around Novo's potential violations of federal securities laws, including the failure to disclose material information to the public, which caused the Company's stock price to plummet.

On March 8, 2023, Novo's stock price fell significantly after the Company announced that it would be delaying the release of its quarterly earnings report. The Company cited "unforeseen circumstances" as the reason for the delay, but failed to provide any additional information to investors.

If you purchased Novo securities between April 29, 2021 and March 8, 2023, you may be entitled to compensation. Please contact Faruqi & Faruqi, LLP to learn more about your rights.

The deadline to file a claim is April 10, 2023. If you have any information or would like to learn more about this investigation, please contact Faruqi & Faruqi, LLP at 1-877-247-4292 or investorinfo@farquifaruqi.com.